Literature DB >> 24008611

Papillary thyroid carcinoma and medicolegal considerations.

F Massoni1, C Simeone, P Ricci, E Onofri, S Ricci.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24008611

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


× No keyword cloud information.
  4 in total

1.  miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.

Authors:  Chen Huang; Zhaogeng Cai; Mingzhu Huang; Chaoming Mao; Qifa Zhang; Yi Lin; Xiaomei Zhang; Bi Tang; Yuqing Chen; Xiaojing Wang; Zhongqing Qian; Lei Ye; Yongde Peng; Huanbai Xu
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

2.  LMO3 promotes proliferation and metastasis of papillary thyroid carcinoma cells by regulating LIMK1-mediated cofilin and the β-catenin pathway.

Authors:  Zeyi Ling; Xiaoli Long; Ying Wu; Jie Li; Mingliang Feng
Journal:  Open Med (Wars)       Date:  2022-03-07

3.  Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.

Authors:  Mei Li; Hui-Fang Chai; Fei Peng; Yu-Ting Meng; Li-Zhi Zhang; Lin Zhang; Hong Zou; Qi-Lan Liang; Man-Man Li; Kai-Ge Mao; Dong-Xu Sun; Meng-Ying Tong; Zi-Qian Deng; Zhi-Jie Hou; Yi Zhao; Jia Li; Xiao-Chao Wang; Sha-Sha Lv; Qing-Qing Zhang; Xiao Yu; Eric W-F Lam; Quentin Liu; Xiao-Nan Cui; Jie Xu
Journal:  Cell Death Dis       Date:  2018-11-02       Impact factor: 8.469

4.  Calcitriol enhances Doxorubicin-induced apoptosis in papillary thyroid carcinoma cells via regulating VDR/PTPN2/p-STAT3 pathway.

Authors:  Ting Zhang; Liang He; Zhihong Wang; Wenwu Dong; Wei Sun; Yuan Qin; Ping Zhang; Hao Zhang
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.